Prevention of second primary tumours with a second generation retinoid in squamous cell carcinoma of oral cavity and oropharynx: long term follow-up.
Bolla
M
M
Laplanche
A
A
Lefur
R
R
Ton Van
J
J
Domenge
C
C
Lefebvre
J L
JL
Luboinski
B
B
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D004311:Double-Blind Method; D005050:Etretinate / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000473:pathology*; D006801:Humans; D016609:Neoplasms, Second Primary / Q000517:prevention & control*
D000970:Antineoplastic Agents; D005050:Etretinate